TScan Therapeutics Inc (TCRX) Price
TCRX Stock Price Chart
TCRX Financial
TScan Therapeutics Inc
$1.09
0%
$0
$1.1
1%
$0.01
Income
Balance sheet
Cash flow
Annual
Quarterly
TCRX Income
Financials in millions USD. Fiscal year is February - January.
| Breakdown | TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 |
|---|---|---|---|---|---|---|
| Revenue | 6 | 2 | 21 | 13 | 10 | 1 |
| Revenue Growth (YoY) | -50% | -90% | 62% | 30% | 900% | -- |
| Cost of Revenue | -- | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- | -- |
| Selling, General & Admin | 32 | 30 | 26 | 20 | 13 | 6 |
| Research & Development | 117 | 107 | 88 | 59 | 44 | 20 |
| Operating Expenses | 152 | 137 | 114 | 80 | 58 | 27 |
| Other Non Operating Income (Expenses) | -- | -- | -- | -- | -- | -- |
| Pretax Income | -136 | -127 | -89 | -66 | -48 | -26 |
| Income Tax Expense | -- | -- | -- | -- | -- | -- |
| Net Income | -136 | -127 | -89 | -66 | -48 | -26 |
| Net Income Growth | 31% | 43% | 35% | 38% | 85% | 100% |
| Shares Outstanding (Diluted) | 129.73 | 111.99 | 65.59 | 24.05 | 23.59 | 23.59 |
| Shares Change (YoY) | 14% | 71% | 173% | 2% | 0% | 0% |
| EPS (Diluted) | -1.05 | -1.13 | -1.36 | -2.75 | -2.06 | -1.11 |
| EPS Growth | 14% | -16% | -51% | 34% | 86% | 91% |
| Free Cash Flow | -131 | -114 | -64 | -70 | -58 | -7 |
| Free Cash Flow Per Share | -1 | -1.01 | -0.97 | -2.91 | -2.45 | -0.29 |
| Gross Margin | -- | -- | -- | -- | -- | -- |
| Operating Margin | -2,416.66% | -6,700% | -442.85% | -507.69% | -480% | -2,600% |
| Profit Margin | -2,266.66% | -6,350% | -423.8% | -507.69% | -480% | -2,600% |
| Free Cash Flow Margin | -2,183.33% | -5,700% | -304.76% | -538.46% | -580% | -700% |
| EBITDA | -142 | -130 | -88 | -61 | -45 | -25 |
| EBITDA Margin | -2,366.66% | -6,500% | -419.04% | -469.23% | -450% | -2,500% |
| D&A For EBITDA | 3 | 4 | 5 | 5 | 3 | 1 |
| EBIT | -145 | -134 | -93 | -66 | -48 | -26 |
| EBIT Margin | -2,416.66% | -6,700% | -442.85% | -507.69% | -480% | -2,600% |
| Effective Tax Rate | -- | -- | -- | -- | -- | -- |
Follow-Up Questions
TScan Therapeutics Inc의 주요 재무제표는 무엇인가요?
TCRX의 주요 재무 비율은 무엇인가요?
TScan Therapeutics Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
TScan Therapeutics Inc은 수익성이 있나요?
TScan Therapeutics Inc에 부채가 있나요?
TScan Therapeutics Inc의 발행 주식은 몇 주인가요?
Features
Trading Strategies
Resources
© 2025 Edgen Powered by
Ask AI About TCRX